Medical News Update
- Rare Disease Drug Approvals
- What's New Related to Drugs
- Pain and Arthritis Products Containing Hidden Ingredients
- Xian Ling may be harmful due to hidden drug ingredients
- Tawon Liar contains hidden drug ingredient
- Rare Disease News, Events & Reports
- Weight Loss Product Notifications
- Drug Alerts and Statements
- FDA Approves First Generics of Gilotrif (afatinib) Tablets
- Oncology (Cancer)/Hematologic Malignancies Approval Notifications
- FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer
- FDA grants traditional approval to selpercatinib for locally advanced or metastatic RET fusion-positive solid tumors
- July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee - 07/23/2026
- Generic Drug Facilities, Sites and Organization Lists
- Registered Outsourcing Facilities
- Notifications on Data Integrity
- Compounding Quality Center of Excellence | Engage with the Compounding Quality Center of Excellence
- Competitive Generic Therapy Approvals
- Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants
- Spa De Soleil, Inc. - 728508 - 07/08/2026